JOURNAL OF ANTIBIOTICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2021-12-29 MS54455111222

摘要超过杂志社要求字数如何缩减？删除哪部分？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2021-12-27 MS54455111222

如何让审稿人读完摘要就可以了解我的研究？

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2018-01-13 kobe24song

审稿速度:2.0
经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。
Decision Sent to Author 12th Jan 18 08:19:11
Under Review 10th Jan 18 23:39:46
Decision sent to Author 10th Jan 18 23:39:46
Manuscript under editorial consideration 28th Dec 17 09:27:15
Under Review 28th Dec 17 08:44:58
With Editorial Office 28th Dec 17 08:44:58
Manuscript submitted 27th Dec 17 04:00:32

245 0

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2014-04-09 dongmu85

审稿速度:3.0 | 投稿命中率:75.0
经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。

355 0

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2013-07-01 pingjian888

跨过2分了，明年会不会再略冲冲，很有希望

322 0

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2012-06-17 yunzhonghe

审稿速度:2.0 | 投稿命中率:50.0
经验分享：个人的第一篇文章。
第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。

第二次送审，2个月后审稿意见回来，小修后接收。

感觉专业性还是蛮强的。

209 0

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2012-02-02 ppswppp

这个杂志很稳定。

355 0

[GetPortalCommentsPageByObjectIdResponse(id=1092448, encodeId=0631109244852, content=摘要超过杂志社要求字数如何缩减？删除哪部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092447, encodeId=d6be109244efc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551271, encodeId=1ac65512e191, content=审稿速度:2.0 经验分享：处理速度比较慢，而且投稿状态很奇怪。under review了，结果还是在编辑那，以内容不符合杂志的偏重方向拒稿，没有被送审。该杂志喜欢植物、微生物发酵产物的分离提取和抗菌活性测试。重在化合物有抗菌活性。如果是已知化合物测抗菌活性还是不要投了，浪费时间。 Decision Sent to Author 12th Jan 18 08:19:11 Under Review 10th Jan 18 23:39:46 Decision sent to Author 10th Jan 18 23:39:46 Manuscript under editorial consideration 28th Dec 17 09:27:15 Under Review 28th Dec 17 08:44:58 With Editorial Office 28th Dec 17 08:44:58 Manuscript submitted 27th Dec 17 04:00:32, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Sat Jan 13 05:11:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502255, encodeId=9bef502255f5, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：13年投了一篇，编辑还是很仔细的，他们会针对你的文章，让你补充一些经典的数据，让你的PAPER信息全面。总的来说，还是不错的，日本编辑真的认真仔细，仪器材料软件都要写明公司以及公司的地址，参考文献都审查的很仔细，我估计他们是有专业的软件检测。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10a692361, createdName=dongmu85, createdTime=Wed Apr 09 17:57:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497467, encodeId=a7d849e467a0, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488965, encodeId=321848896540, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：个人的第一篇文章。 第一次被拒稿，要补充其他的生物活性（新型抗生素的其他活性）。 第二次送审，2个月后审稿意见回来，小修后接收。 感觉专业性还是蛮强的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc139633, createdName=yunzhonghe, createdTime=Sun Jun 17 08:49:00 CST 2012, time=2012-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486480, encodeId=ec8a486480e8, content=这个杂志很稳定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b0939285, createdName=ppswppp, createdTime=Thu Feb 02 11:08:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816761, encodeId=5856816e6125, content=新化合物，有活性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Thu Nov 03 12:11:00 CST 2011, time=2011-11-03, status=1, ipAttribution=)]

2011-11-03 ms1562262113729736

新化合物，有活性

96 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务